437 related articles for article (PubMed ID: 6255005)
61. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
Davies M; Mawer EB; Adams PH
J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
[TBL] [Abstract][Full Text] [Related]
62. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
63. [Treatment of postmenopausal osteoporosis with 1-alpha(OH)D3].
Petkakov M; Popović V; Milić D; Damjanović S; Manojlović D; Mićić J
Srp Arh Celok Lek; 1995; 123(7-8):171-3. PubMed ID: 17974421
[TBL] [Abstract][Full Text] [Related]
64. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
Christiansen C; Rødbro P; Naestoft J; Christensen MS
Clin Endocrinol (Oxf); 1981 Sep; 15(3):237-42. PubMed ID: 6273028
[TBL] [Abstract][Full Text] [Related]
65. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
[TBL] [Abstract][Full Text] [Related]
66. Vitamin D supplementation in elderly nursing home residents increases 25(OH)D but not 1,25(OH)2D.
Himmelstein S; Clemens TL; Rubin A; Lindsay R
Am J Clin Nutr; 1990 Oct; 52(4):701-6. PubMed ID: 2403063
[TBL] [Abstract][Full Text] [Related]
67. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
[TBL] [Abstract][Full Text] [Related]
68. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.
Tsai KS; Heath H; Kumar R; Riggs BL
J Clin Invest; 1984 Jun; 73(6):1668-72. PubMed ID: 6327768
[TBL] [Abstract][Full Text] [Related]
69. Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency.
Rude RK; Adams JS; Ryzen E; Endres DB; Niimi H; Horst RL; Haddad JG; Singer FR
J Clin Endocrinol Metab; 1985 Nov; 61(5):933-40. PubMed ID: 3840173
[TBL] [Abstract][Full Text] [Related]
70. Studies on the hydroxylation of vitamin D in man.
Loré F; Di Cairano G
Ann Med Interne (Paris); 1986; 137(3):206-8. PubMed ID: 3767185
[TBL] [Abstract][Full Text] [Related]
71. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.
Riggs BL; Jowsey J; Goldsmith RS; Kelly PJ; Hoffman DL; Arnaud CD
J Clin Invest; 1972 Jul; 51(7):1659-63. PubMed ID: 4338118
[TBL] [Abstract][Full Text] [Related]
72. Effect of estrogen on vitamin D metabolism in tall girls.
Aarskog D; Aksnes L; Markestad T; Rødland O
J Clin Endocrinol Metab; 1983 Dec; 57(6):1155-8. PubMed ID: 6605356
[TBL] [Abstract][Full Text] [Related]
73. Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.
Heikkinen A; Parviainen MT; Tuppurainen MT; Niskanen L; Komulainen MH; Saarikoski S
Calcif Tissue Int; 1998 Jan; 62(1):26-30. PubMed ID: 9405729
[TBL] [Abstract][Full Text] [Related]
74. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.
Duda RJ; Kumar R; Nelson KI; Zinsmeister AR; Mann KG; Riggs BL
J Clin Invest; 1987 Apr; 79(4):1249-53. PubMed ID: 3494046
[TBL] [Abstract][Full Text] [Related]
75. Effects of aluminum hydroxide on the parathyroid-vitamin D axis of postmenopausal women.
Villa ML; Packer E; Cheema M; Holloway L; Marcus R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1256-61. PubMed ID: 1955506
[TBL] [Abstract][Full Text] [Related]
76. The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans.
Adams ND; Garthwaite TL; Gray RW; Hagen TC; Lemann J
J Clin Endocrinol Metab; 1979 Oct; 49(4):628-30. PubMed ID: 573283
[TBL] [Abstract][Full Text] [Related]
77. Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.
Francis RM; Peacock M
Am J Clin Nutr; 1987 Aug; 46(2):315-8. PubMed ID: 3618534
[TBL] [Abstract][Full Text] [Related]
78. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
Unakami H
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):234-47. PubMed ID: 6980145
[TBL] [Abstract][Full Text] [Related]
79. Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.
Brown SA; Ontjes DA; Lester GE; Lark RK; Hensler MB; Blackwood AD; Caminiti MJ; Backlund DC; Aris RM
Osteoporos Int; 2003 Jun; 14(5):442-9. PubMed ID: 12774194
[TBL] [Abstract][Full Text] [Related]
80. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
